[Skip to Content]
[Skip to Content Landing]
June 22, 1929


Author Affiliations

BOSTON; ROCHESTER, N. Y.; ROCHESTER, MINN.; WASHINGTON, D. C.; Chairman Special Committee Appointed by the Therapeutic Research Committee of the Council on Pharmacy and Chemistry NEW YORK

JAMA. 1929;92(25):2099-2101. doi:10.1001/jama.1929.92700510003010

VI. THE INTRAVENOUS USE OF GLANDULAR PRODUCTS  A careful consideration of the actual indications for the intravenous use of drugs and of the nature of glandular products and of their action in the body would seem to indicate that their injection directly into the vein is seldom, if ever, necessary or justifiable.The subcutaneous administration of drugs has been used in practice for many years. Relatively speaking, it is a familiar field. Drugs so administered are, as a rule, more rapidly absorbed and exert a more rapid and powerful effect than when given by mouth. But their hypodermic use has necessitated a nice adjustment in relation to refinement of the drugs and the dose to be employed. Even so, one frequently sees evidence of the overaction of drugs when so administered. With intravenous use, the body is instantaneously and irrevocably exposed to the sudden action of the drug, and calamitous results cannot be avoided at times except

First Page Preview View Large
First page PDF preview
First page PDF preview